Loading patent…
AssigneeNutramax Laboratories, Inc.
InventorsCarmelita Frondoza, Todd Henderson, Reinhard Grzanna
Estimating the term…
An orally administrable composition for treating or reducing damage to connective tissue or for treating or reducing inflammatory symptoms associated with damage to connective tissue includes a synergistic combination of: (i) avocado/soybean unsaponifiables; and (ii) lipoic acid, or a salt or derivative thereof. Methods for treating or reducing damage to connective tissue, for treating or reducing inflammatory symptoms associated with damage to connective tissue, or for reducing levels of one or more inflammatory mediators in connective tissue include administering the orally administrable composition to an avian or mammalian subject.
An orally administrable composition for treating or reducing damage to connective tissue, or for treating or reducing inflammatory symptoms associated with damage to connective tissue, comprising a synergistic combination of:
A method for treating or reducing damage to connective tissue or for treating or reducing inflammatory symptoms associated with damage to connective tissue in an avian or mammalian subject, comprising orally administering to the subject a composition comprising a synergistic combination of:
A method of reducing levels of one or more inflammatory mediators in connective tissue, comprising orally administering to an avian or mammalian subject a composition in an amount effective to decrease inflammation, the composition comprising a synergistic combination of:
Dependencies are inferred from the claim text.